Postpartum Period
Conditions
Interventions
This is a randomized double-blind clinical trial with prospective follow-up, designed according to the guidelines of the Consolidated Standards of Reporting Trials (Consort). To carry out the study, t
48.7%) and center B (n=2,730
51.3%) in the year 2020, extracted from Live Births Information System (Sinasc). A collaborator not involved in the study will carry out an electronic draw that generates a list of random numbers on t
E02.594.540
Sponsors
Universidade Estadual de Londrina - UEL
Centro de Ciências da Saúde - Departamento de Enfermagem
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Mothers who are allocated in the rooming-in of the participating maternity hospitals; single pregnancy; gestational age equal to or greater than 37 weeks; nursing their babies; who has a smartphone to enable follow-up in the survey
Exclusion criteria
Exclusion criteria: Contraindication to breastfeeding; unpretentiousness to breastfeed; child with clinical conditions that may interfere with or prevent breastfeeding during the research period; anomalies in the breasts and/or nipples that may interfere with the breastfeeding process; contraindications for local photobiomodulation or transcutaneous ILIB: diagnosis of autoimmune disease (lupus or rheumatoid arthritis); tumor diagnosis; using antiplatelet medications; previous history of malignant pathology; pacemaker carrier, glaucoma; prior photosensitivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that Photobiomodulation will help in pain management, reducing the incidence and intensity of pain resulting from breastfeeding. If the hypothesis is correct, photobiomodulation could be a therapy that will contribute to reducing the suffering resulting from breastfeeding, reducing early weaning, increasing the rates of prolonged exclusive breastfeeding and improving the health of children and women involved in the breastfeeding process | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that Photobiomodulation will contribute to reducing the incidence of nipple injuries resulting from breastfeeding. Photobiomodulation may be a therapy used in pain management, injury prevention, thus contributing to the reduction of injuries and suffering resulting from breastfeeding, reduction of early weaning, increase in rates of prolonged exclusive breastfeeding and improvement of the health of children and women involved in the breastfeeding process | — |
Countries
Brazil
Contacts
Public ContactCamila Carla Leite
Centro de Ciências da Saúde - Departamento de Enfermagem
Outcome results
None listed